FDA designates Kite for Priority Review with an action date (PDUFA) of November 29th.
Now, that is my birthday so this has to be good news, right?
Kidding aside, my calls expire in January 2018. So I’m glad to see a potential catalyst before then. Of course, this could be a potential “de-catalyst.” I didn’t have a good antonym for catalyst, sorry.
I created this position as a gamble. I could have pulled my cost out of it and let the profits run, but that really isn’t how I gamble. I invest differently, but this is just gambling for me so let’s see what happens.